NSW Health Drug and Therapeutics Advisory Community of Practice for COVID-19
The Drug and Therapeutics Advisory Community of Practice (DaTA CoP) aims to provide an opportunity for sharing ideas, strategies, solutions, concerns and escalation pathway with respect to COVID-19 Pandemic preparedness.
NSW TAG was the coordinating DaTA CoP secretariat until mid-October 2021. Co-chairs were: Prof Sarah Hilmer and Ms Jenny Crane.
The CEC has now taken over secretariat functions of the DaTA CoP. If you would like to join the Community, wish to share any information or raise any concerns, please visit the CEC webpage or contact CEC-Therapeutics@health.nsw.gov.au
See also other communities of practice in NSW established across key clinical specialties to support the response to COVID-19.
2021 Temporary register of life-saving medicines for COVID-19-related issues
A temporary COVID-19 Life Saving Drugs Register (LSDR) was created in May 2021 to enable ready access to medicines for COVID-19-related issues following discussions at the NSW COVID-19 Drug and Therapeutics Advisory Community of Practice meetings. The latest version of the temporary Register (last updated 30/8/21) listed fondaparinux, one of a number of therapeutic options for managing Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT). The temporary register is now no longer required and has been removed.
Contact firstname.lastname@example.org if you would like a copy.
Resources for Medicines Use in the Treatment of COVID-19
Activities & news
|TAG Mail||DaTA CoP SharePoint||Clinical Trials Summary Table|
|Our weekly Tag Mail newsletter now has a dedicated COVID-19 section keeping you up-to-date with the latest national and international news and articles relevant to COVID-19. Available||
The SharePoint site includes list of COVID-19-related enquiries to NSW Medicines Information Pharmacists. Members only site
|A summary table outlining currently registered Clinical Trials relating to treatment/prophylaxis for COVID-19 within NSW public hospitals is available (last updated 13 September 2021)|
Page last updated: 24 November 2021